Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Confidential contracting

- PMLiVE

Astellas Pharma’s non-hormonal menopause drug granted FDA approval

Vasomotor symptoms affect up to 80% of menopausal individuals in the US

- PMLiVE

Research finds a third with dementia concerns face long wait for medical help

It is estimated that by 2040 1.6m people will suffer from dementia in the UK

- PMLiVE

WHO report shows progress as well as gaps in AMR antibiotic pipeline

AMR has been declared as one of the top ten global public health threats by the organisation

Patient Support Program (PSP) Optimization: A Customer Story

Our client was looking to gather detailed feedback on their Patient Support Program (PSP) in order to improve its useability, offerings, and value to patients and caregivers. Working closely with...

Impetus Digital

- PMLiVE

Spotting the Signs of Dementia is the First Step to Diagnosis

As part of our contribution to dementia awareness week, we wanted to help ground people in the terms often used interchangeably to describe dementia.

Mednet

- PMLiVE

Bristol Myers Squibb’s Sotyktu approved by MHRA for plaque psoriasis

Up to 1.8 million people in the UK are affected by some form of the inflammatory condition

- PMLiVE

GSK’s five-in-one meningococcal vaccine candidate shows promise in phase 3 trial

There are no approved vaccines offering simultaneous protection against all five serogroups

The future for Pharmacists is here

CHASE and Medacy will be in attendance at this year's Clinical Pharmacy Congress (CPC) on 12 - 13 May 2023 at the ExCeL Centre in London.

CHASE

- PMLiVE

CHASE and Medacy will be attending Clinical Pharmacy Congress 2023

CHASE and Medacy will be in attendance at this year's Clinical Pharmacy Congress (CPC) on 12 - 13 May 2023 at the ExCeL Centre in London.

CHASE

- PMLiVE

Caroline Pond joins CHASE as NHS Partnership Working Director

CHASE is delighted to welcome Caroline Pond as NHS Partnership Working Director.

CHASE

- PMLiVE

GSK welcomes Canadian court ruling to dismiss Zantac litigation

The company and other drugmakers have been facing thousands of lawsuits claiming ranitidine caused cancer

- PMLiVE

Amgen and TScan Therapeutics partner to identify new Crohn’s disease targets

Inflammatory bowel disease affects nearly one in every 100 people in the US

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links